Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients

Summary

Phase II study to evaluate the clinical potential of 68GaNOTA-anti-MMR-VHH2 for in vivo imaging of Macrophage Mannose Receptor (MMR)-expressing Macrophages by means of Positron Emission Tomography (PET) in patients with non-small cell lung cancer (NSCLC) planned for surgical resection.

Timeline

Start

2023-03-30

Primary completion

2027-04-01

Completion

2027-04-01

Drugs

Indications